ArticleSAGE open medicine2018

Effectiveness and safety of sofosbuvir/ledipasvir ± ribavirin treatment in liver and/or renal transplant patients with chronic hepatitis C: A single-center experience.

Mete Akin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.